Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Clinical trial NCT00532909 · COMPLETED

Trial details

NCT number: NCT00532909
Sponsor: Branimir Sikic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anal, Colon, and Rectal Cancers Colorectal Neoplasms Colon/Rectal Cancer

Start date: 2006-07-01
Primary completion: 2010-05-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.